Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expressions. The company's products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics and age-related disease diagnostics. Oxford Biodynamics is headquartered in Oxford, Oxfordshire, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oxford Biodynamics Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Oxford Biodynamics Plc Company Overview
- Oxford Biodynamics Plc Company Snapshot
- Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview
- Oxford Biodynamics Plc - Pipeline Analysis Overview
- Oxford Biodynamics Plc - Key Facts
- Oxford Biodynamics Plc - Major Products and Services
- Oxford Biodynamics Plc Pipeline Products by Development Stage
- Oxford Biodynamics Plc Ongoing Clinical Trials by Trial Status
- Oxford Biodynamics Plc Pipeline Products Overview
- Companion Diagnostic Test - Amyotrophic Lateral Sclerosis
- Companion Diagnostic Test - Amyotrophic Lateral Sclerosis Product Overview
- Companion Diagnostic Test - Corticobasal Degeneration
- Companion Diagnostic Test - Corticobasal Degeneration Product Overview
- Companion Diagnostic Test - Dementia With Lewy Bodies
- Companion Diagnostic Test - Dementia With Lewy Bodies Product Overview
- Companion Diagnostic Test - Diffuse Lewy Body Disease
- Companion Diagnostic Test - Diffuse Lewy Body Disease Product Overview
- Companion Diagnostic Test - Frontotemporal Lobar Degeneration
- Companion Diagnostic Test - Frontotemporal Lobar Degeneration Product Overview
- Companion Diagnostic Test - Multiple System Atrophy
- Companion Diagnostic Test - Multiple System Atrophy Product Overview
- Companion Diagnostic Test - Osteoporosis
- Companion Diagnostic Test - Osteoporosis Product Overview
- Companion Diagnostic Test - Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex
- Companion Diagnostic Test - Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex Product Overview
- Companion Diagnostic Test - Progressive Supranuclear Palsy
- Companion Diagnostic Test - Progressive Supranuclear Palsy Product Overview
- Companion Diagnostic Test - Sarcopenia
- Companion Diagnostic Test - Sarcopenia Product Overview
- EpiSwitch Alzheimer’s Disease Diagnostic Test
- EpiSwitch Alzheimer’s Disease Diagnostic Test Product Overview
- EpiSwitch Assay - Autism
- EpiSwitch Assay - Autism Product Overview
- EpiSwitch Biomarker - Concussion
- EpiSwitch Biomarker - Concussion Product Overview
- EpiSwitch Breast Cancer Test
- EpiSwitch Breast Cancer Test Product Overview
- EpiSwitch Diagnostic Assay - Amyotrophic Lateral Sclerosis
- EpiSwitch Diagnostic Assay - Amyotrophic Lateral Sclerosis Product Overview
- EpiSwitch Diagnostic Assay - Amyotrophic Lateral Sclerosis Clinical Trial
- EpiSwitch Diffuse Large B-Cell Lymphoma Test
- EpiSwitch Diffuse Large B-Cell Lymphoma Test Product Overview
- EpiSwitch Liver Cancer Test
- EpiSwitch Liver Cancer Test Product Overview
- EpiSwitch Melanoma Companion Diagnostic Assay
- EpiSwitch Melanoma Companion Diagnostic Assay Product Overview
- EpiSwitch Melanoma Test
- EpiSwitch Melanoma Test Product Overview
- EpiSwitch Melanoma Test - Prognosis
- EpiSwitch Melanoma Test - Prognosis Product Overview
- EpiSwitch Melanoma Test - Residual Disease Monitoring
- EpiSwitch Melanoma Test - Residual Disease Monitoring Product Overview
- EpiSwitch Nasopharyngeal Cancer Test
- EpiSwitch Nasopharyngeal Cancer Test Product Overview
- EpiSwitch Parkinson’s Disease Diagnostic Test
- EpiSwitch Parkinson’s Disease Diagnostic Test Product Overview
- EpiSwitch Primary Progressive Multiple Sclerosis Test
- EpiSwitch Primary Progressive Multiple Sclerosis Test Product Overview
- EpiSwitch Prognostic Assay - Amyotrophic Lateral Sclerosis
- EpiSwitch Prognostic Assay - Amyotrophic Lateral Sclerosis Product Overview
- EpiSwitch Prognostic Assay - Tyrosine Kinase Inhibitors
- EpiSwitch Prognostic Assay - Tyrosine Kinase Inhibitors Product Overview
- EpiSwitch Prostate Cancer Prognostic Assay
- EpiSwitch Prostate Cancer Prognostic Assay Product Overview
- EpiSwitch Relapsing Remitting Multiple Sclerosis Test
- EpiSwitch Relapsing Remitting Multiple Sclerosis Test Product Overview
- EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test
- EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test Product Overview
- EpiSwitch Systemic Lupus Erythematosus Prognostic Test
- EpiSwitch Systemic Lupus Erythematosus Prognostic Test Product Overview
- EpiSwitch T1DM Diagnostic Test
- EpiSwitch T1DM Diagnostic Test Product Overview
- EpiSwitch T1DM Prognostic Test
- EpiSwitch T1DM Prognostic Test Product Overview
- EpiSwitch T2DM Prognostic Test
- EpiSwitch T2DM Prognostic Test Product Overview
- EpiSwitch Test - Huntington's Disease
- EpiSwitch Test - Huntington's Disease Product Overview
- EpiSwitch Thyroid Cancer Diagnostic Test
- EpiSwitch Thyroid Cancer Diagnostic Test Product Overview
- EpiSwitch Ulcerative Colitis Test
- EpiSwitch Ulcerative Colitis Test Product Overview
- Oxford Biodynamics Plc - Key Competitors
- Oxford Biodynamics Plc - Key Employees
- Oxford Biodynamics Plc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Oxford Biodynamics Plc, Recent Developments
- Apr 03, 2024: Oxford Biodynamics opens clinical testing facility in the UK to perform EpiSwitch Prostate Screening (PSE) blood test
- Nov 08, 2023: Oxford Biodynamics Strengthens Commercial Leadership With New SVP of Business and Corporate Development
- Oct 03, 2023: Oxford Biodynamics Receives Reimbursement Code for Episwitch Prostate Screening (PSE) Test
- Sep 26, 2023: Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch Prostate Screening Blood Test to Men With Prostate Cancer Risk
- May 16, 2023: Oxford BioDynamics notice of interim results and investor webinar
- May 15, 2023: Oxford BioDynamics : Peer-reviewed study results confirm and expand validation of Oxford BioDynamics' EpiSwitch CiRT blood test for checkpoint inhibitor immunotherapies
- May 02, 2023: Oxford Biodynamics Granted US Foundation of NIH Pact Award for Prognosis of Cancer Patients with IO-Triggered Hyper-Progressive Disease
- Apr 05, 2023: Business update - plan to launch Prostate Screening EpiSwitch test by end of 2023; sales progress for flagship EpiSwitch CiRT
- Feb 08, 2023: The new prostate cancer blood test with 94 per cent accuracy
- Feb 06, 2023: Oxford BioDynamics’ prostate screening EpiSwitch blood test significantly enhances overall detection accuracy for at risk men
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview
- Oxford Biodynamics Plc Pipeline Products by Equipment Type
- Oxford Biodynamics Plc Pipeline Products by Indication
- Oxford Biodynamics Plc Ongoing Clinical Trials by Trial Status
- Oxford Biodynamics Plc, Key Facts
- Oxford Biodynamics Plc, Major Products and Services
- Oxford Biodynamics Plc Number of Pipeline Products by Development Stage
- Oxford Biodynamics Plc Pipeline Products Summary by Development Stage
- Oxford Biodynamics Plc Ongoing Clinical Trials by Trial Status
- Oxford Biodynamics Plc Ongoing Clinical Trials Summary
- Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Status
- Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Description
- Companion Diagnostic Test - Corticobasal Degeneration - Product Status
- Companion Diagnostic Test - Corticobasal Degeneration - Product Description
- Companion Diagnostic Test - Dementia With Lewy Bodies - Product Status
- Companion Diagnostic Test - Dementia With Lewy Bodies - Product Description
- Companion Diagnostic Test - Diffuse Lewy Body Disease - Product Status
- Companion Diagnostic Test - Diffuse Lewy Body Disease - Product Description
- Companion Diagnostic Test - Frontotemporal Lobar Degeneration - Product Status
- Companion Diagnostic Test - Frontotemporal Lobar Degeneration - Product Description
- Companion Diagnostic Test - Multiple System Atrophy - Product Status
- Companion Diagnostic Test - Multiple System Atrophy - Product Description
- Companion Diagnostic Test - Osteoporosis - Product Status
- Companion Diagnostic Test - Osteoporosis - Product Description
- Companion Diagnostic Test - Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex - Product Status
- Companion Diagnostic Test - Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex - Product Description
- Companion Diagnostic Test - Progressive Supranuclear Palsy - Product Status
- Companion Diagnostic Test - Progressive Supranuclear Palsy - Product Description
- Companion Diagnostic Test - Sarcopenia - Product Status
- Companion Diagnostic Test - Sarcopenia - Product Description
- EpiSwitch Alzheimer’s Disease Diagnostic Test - Product Status
- EpiSwitch Alzheimer’s Disease Diagnostic Test - Product Description
- EpiSwitch Assay - Autism - Product Status
- EpiSwitch Assay - Autism - Product Description
- EpiSwitch Biomarker - Concussion - Product Status
- EpiSwitch Biomarker - Concussion - Product Description
- EpiSwitch Breast Cancer Test - Product Status
- EpiSwitch Breast Cancer Test - Product Description
- EpiSwitch Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Status
- EpiSwitch Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Description
- EpiSwitch Diagnostic Assay - Amyotrophic Lateral Sclerosis - Radicava (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
- EpiSwitch Diffuse Large B-Cell Lymphoma Test - Product Status
- EpiSwitch Diffuse Large B-Cell Lymphoma Test - Product Description
- EpiSwitch Liver Cancer Test - Product Status
- EpiSwitch Liver Cancer Test - Product Description
- EpiSwitch Melanoma Companion Diagnostic Assay - Product Status
- EpiSwitch Melanoma Companion Diagnostic Assay - Product Description
- EpiSwitch Melanoma Test - Product Status
- EpiSwitch Melanoma Test - Product Description
- EpiSwitch Melanoma Test - Prognosis - Product Status
- EpiSwitch Melanoma Test - Prognosis - Product Description
- EpiSwitch Melanoma Test - Residual Disease Monitoring - Product Status
- EpiSwitch Melanoma Test - Residual Disease Monitoring - Product Description
- EpiSwitch Nasopharyngeal Cancer Test - Product Status
- EpiSwitch Nasopharyngeal Cancer Test - Product Description
- EpiSwitch Parkinson’s Disease Diagnostic Test - Product Status
- EpiSwitch Parkinson’s Disease Diagnostic Test - Product Description
- EpiSwitch Primary Progressive Multiple Sclerosis Test - Product Status
- EpiSwitch Primary Progressive Multiple Sclerosis Test - Product Description
- EpiSwitch Prognostic Assay - Amyotrophic Lateral Sclerosis - Product Status
- EpiSwitch Prognostic Assay - Amyotrophic Lateral Sclerosis - Product Description
- EpiSwitch Prognostic Assay - Tyrosine Kinase Inhibitors - Product Status
- EpiSwitch Prognostic Assay - Tyrosine Kinase Inhibitors - Product Description
- EpiSwitch Prostate Cancer Prognostic Assay - Product Status
- EpiSwitch Prostate Cancer Prognostic Assay - Product Description
- EpiSwitch Relapsing Remitting Multiple Sclerosis Test - Product Status
- EpiSwitch Relapsing Remitting Multiple Sclerosis Test - Product Description
- EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test - Product Status
- EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test - Product Description
- EpiSwitch Systemic Lupus Erythematosus Prognostic Test - Product Status
- EpiSwitch Systemic Lupus Erythematosus Prognostic Test - Product Description
- EpiSwitch T1DM Diagnostic Test - Product Status
- EpiSwitch T1DM Diagnostic Test - Product Description
- EpiSwitch T1DM Prognostic Test - Product Status
- EpiSwitch T1DM Prognostic Test - Product Description
- EpiSwitch T2DM Prognostic Test - Product Status
- EpiSwitch T2DM Prognostic Test - Product Description
- EpiSwitch Test - Huntington's Disease - Product Status
- EpiSwitch Test - Huntington's Disease - Product Description
- EpiSwitch Thyroid Cancer Diagnostic Test - Product Status
- EpiSwitch Thyroid Cancer Diagnostic Test - Product Description
- EpiSwitch Ulcerative Colitis Test - Product Status
- EpiSwitch Ulcerative Colitis Test - Product Description
- Oxford Biodynamics Plc, Key Employees
- Glossary
- Oxford Biodynamics Plc Pipeline Products by Equipment Type
- Oxford Biodynamics Plc Pipeline Products by Development Stage
- Oxford Biodynamics Plc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Almac Discovery Ltd
- Ossianix Inc
- ABS Laboratories Ltd
- Aktogen Ltd
- LGC Ltd
- InHealth
